According to the new market research report Single use Bioreactors Market is projected to reach USD 3.9 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 18.0% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750
Increasing adoption of SUBs among small companies and startups,
technological advancements in SUBs, reduced automation complexity, ease
in the cultivation of marine organisms, reduced energy and water
consumption, the growing biologics market and increasing
Biopharmaceutical R&D are factors driving the growth of this market.
Based on product, the Single use Bioreactors Market is categorized into
single-use bioreactor systems, single-use media bags, single-use
filtration assemblies, and other products such as single-use vessels,
tubing, connectors, control systems, and probes/sensors, among others.
The single-use bioreactor systems segment dominated the market in 2019.
SUB systems offer benefits such as lower capital investment, lower
operating expenses, and lower environmental footprint, thus driving the
growing adoption of these systems in biopharma applications.
The prominent players operating in the Single use Bioreactors Market are
Thermo Fisher Scientific (US), Sartorius Stedim Biotech (France),
Danaher Corporation (US), and Merck Millipore (Germany).
Opportunity: Emerging markets
The significant growth opportunities offered by emerging countries such
as China, India, and Indonesia can be attributed to high growth in their
respective pharmaceutical & biopharmaceutical sectors due to the
presence of less-stringent regulatory policies as well as low-cost and
skilled labor. Owing to cost advantages and skilled labor, these
countries are a hub for bioprocess outsourcing. Developing countries are
showing faster growth rates in single-use systems. For example, many of
the new bioprocessing facilities are expected to be constructed in
China to meet both domestic demand and its desire to become an exporter
of biopharmaceuticals. China’s biopharma companies also have found CMOs
in China to be more open-minded in adopting single-use technology, as
compared to domestic biologics developers/manufacturers. In 2018, Wuxi
Biologics partnered with ABEC and installed its 4,000-liter Custom
Single Run disposable bioreactors for its new commercial manufacturing
facility in Wuxi city, China.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
In 2019, North America accounted for the largest share of the single-use
bioreactors market, followed by Europe. The large share of the North
American regional segment can be attributed to the presence of a
well-established biopharmaceutical industry and major players operating
in the market.